Position in TWST
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,481,652
+$3,704,452 QoQ
Shares Held
53,282
+42.5% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TWST Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARBOR CAPITAL ADVISORS, INC. holds $33,616,297 across 29 Biotechnology names. TWST ranks #1 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TWST |
Twist Bioscience Corp
This page
|
53,282 | $5,481,652 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
36,368 | $4,170,318 | |
| 3 | VCEL |
Vericel Corp
|
72,852 | $3,241,185 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
36,977 | $2,894,189 | |
| 5 | RARE |
Ultragenyx Pharmaceutical Inc.
|
72,316 | $2,414,631 | |
| 6 | CELC |
Celcuity Inc.
|
19,933 | $2,085,390 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
29,612 | $1,863,779 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
46,550 | $1,727,470 |
All Filings in TWST
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,481,652 | 53,282 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,777,200 | 37,399 | Shares | Sole | 2026-04-28 | |
| 2023-12-31 | $931,894 | 25,282 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $524,673 | 25,897 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $508,124 | 24,835 | Shares | Sole | 2023-07-11 | |
| No filing history on record for this holder in this stock. | ||||||